ClinicalTrials.Veeva

Menu

POGO® Automatic Blood Glucose Monitoring System Clinical Study

I

Intuity Medical

Status

Completed

Conditions

Diabetes Mellitus

Treatments

Device: POGO® BGMS

Study type

Observational

Funder types

Industry

Identifiers

NCT02333864
TP-000321

Details and patient eligibility

About

The purpose of this study is to determine if the POGO® system delivers accurate blood glucose readings in the hands of the lay user and assess the POGO® system accuracy when used by trained health care professionals.

Full description

Subjects will review labeling materials and self-test using the POGO® system. An HCP-assisted test also will be performed; both tests will be compared to a fingerstick capillary sample run on a YSI reference glucose analyzer. Subjects will complete questionnaires on labeling comprehension and POGO® usability.

Enrollment

287 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Be diagnosed with diabetes
  • Be 18 years of age or older
  • Be able to read, write, and understand English fluently
  • Be able and willing to give written informed consent and have provided signed, written consent

Exclusion criteria

  • Any condition which in the opinion of the Investigator may place the subject or site personnel at excessive risk
  • A physical condition or limitation that prevents the subject from reading the labeling and using a BGMS on their own
  • Previous experience with the POGO® BGMS
  • Formal experience with clinical (medical) laboratory equipment or formal training in a relevant medical field

Trial design

287 participants in 1 patient group

PWD testing POGO® BGMS
Description:
All enrolled persons with diabetes
Treatment:
Device: POGO® BGMS

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems